|
Obese Patients with Untreated Dyslipidemias Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Obese Patients with Untreated Dyslipidemias conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Obese Patients with Untreated Dyslipidemias Clinical research trials and Obese Patients with Untreated Dyslipidemias healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Obese Patients with Untreated Dyslipidemias. Obese Patients with Untreated Dyslipidemias Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Obese Patients with Untreated Dyslipidemias clinical trial. Test subjects typically receive the most effective healthcare possible for their Obese Patients with Untreated Dyslipidemias condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "O" Clinical Trials Conditions > Obese Patients with Untreated Dyslipidemias Obese Patients with Untreated Dyslipidemias
Obese Patients with Untreated Dyslipidemias
For Condition: Dyslipidemia,Obesity
Status: Completed
Sponsor(s): Sanofi-Synthelabo ,
Synopsis: To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with untreated dyslipidemia
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/70 Years
Genders: Both
Protocol Entry Criteria: - BMI must be greater than 27 and less than 40 - Patients with untreated dyslipidemia - Stable weight (variation of less than 5 kg within 3 months prior to screening visit)
Total Enrollment: 370
Location and Contact Information:
University of Cincinnati College of Medicine
Cincinnati, Ohio, 45267-0559
United States
Arizona Clinical Research Center, Inc.
Tucson, Arizona, 85712
United States
Altoona Center for Clinical Research
Duncansville, Pennsylvania, 16635
United States
Women's Clinic of Lincoln, PC
Lincoln, Nebraska, 68510
United States
Clinical Research of South Florida
Coral Gables, Florida, 33134
United States
nTouch Research
Peoria, Illinois, 61602
United States
Hunter Holmes McGuire Medical Center Research Service (151)
Richmond, Virginia, 23249
United States
nTouch Research
South Bend, Indiana, 46601
United States
Nashville Medical Research Institute
Nashville, Tennessee, 37205
United States
Vancouver Medical Weight Loss Clinic
Vancouver, Washington, 98685
United States
New Mexico Clinical Research & Osteoporosis Center, Inc.
Albuquerque, New Mexico, 87106
United States
Apexute
Santa Ana, California, 92705
United States
Clinical Research Division
Newtown, Pennsylvania, 18940
United States
Johns Hopkins Women's Research Core
Lutherville, Maryland, 21093
United States
Los Angeles Clinical Trials
Los Angeles, California, 90064
United States
Radiant Research
Edina, Minnesota, 55435
United States
Radiant Research
Stuart, Florida, 34996
United States
Medical University of South Carolina, Division of Clinical Pharmacology
Charleston, South Carolina, 29425
United States
Baystate Medical Center
Springfield, Massachusetts, 01199
United States
Bluegrass Clinical Research, Inc.
Louisville, Kentucky, 40291
United States
Clinical Research Center of Reading, LLC
West Reading, Pennsylvania, 19611-1124
United States
Radiant Research
Salt Lake City, Utah, 84111
United States
Clinic of Physicians and Surgeons, LTD
Mesa, Arizona, 85201
United States
Clinical Research Services
Bismark, North Dakota, 58501
United States
Irvine Center for Clinical Research (ICCR)
Irvine, California, 92618
United States
Twin Cities Clinical Research
Arden Hills, Minnesota, 55126
United States
Addiction & Psychiatric Medicine Research
Morgantown, West Virginia, 26506-9300
United States
Clinical Research Center of Northern Virginia
Falls Church, Virginia, 22044
United States
Additional Information:
Study ID Numbers: EFC4735; SR141716
Study Start Date: September 2001
Record last reviewed: November 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00029835
Other Obesity Studies:
1. Exercise Adherence in a Behavioral Weight Loss Program
2. Prevention of weight gain
3. Genomewide Search for Loci Underlying Metabolic Syndrome
4. Obese Patients with or without Comorbidities
5. Methods for Measuring Insulin Sensitivity
Related Studies:
Other Obesity Clinical Trials
Other Pennsylvania Clinical Trials
Other West Reading Clinical Trials
Obese Patients with Untreated Dyslipidemias
|
|
|
|
|
|
|
|